Advertisement

Topics

Encore Company Profile

20:55 EST 19th November 2017 | BioPortfolio

Based in Los Angeles, CA, Encore is a wholly-owned subsidiary of Navarre Corporation, and a leading retail software publisher. As a result of strategic licensing agreements, the company publishes a broad range of award-winning utility, entertainment, education and productivity software titles. Publishing brands include Hoyle, Marine Aquarium, Family Tree Maker, 3D Home Architect, Advantage, Wheel of Fortune and Jeopardy!; as well as the Riverdeep family of brands including The Print Shop, PrintMaster, Reader Rabbit and Mavis Beacon.


News Articles [17 Associated News Articles listed on BioPortfolio]

Dr. Reddy's Out-Licenses Plaque Psoriasis Drug to Encore Dermatology

NewsDr. Reddy's Laboratories announces the out-licensing of DFD-06 to Encore Dermatology. Under the terms of the agreement, Encore will be responsible for the commercialization of DFD-06 in the United...

Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and ...

Enrollment in all cohorts of ENCORE 601 have proceeded rapidly. The second stage of the ENCORE 601 cohort enrolling PD-1 (programmed death receptor-1) refractory melanoma Read more...

emids Acquires Health IT Consulting Firm Encore Health Resources

emids, a growing global provider of IT services and solutions for the healthcare and life sciences industries, has acquired health IT consulting firm Encore Health Resources. For emids, the acquisitio...

Dr. Reddy's Laboratories Ltd. Announces The Out-Licensing Of DFD-06 To Encore Dermatology

  Life Sciences Jobs   ...

Encore Dermatology gets rights to psoriasis drug DFD-06

Dr Reddy’s Laboratories, through its wholly-owned US subsidiary Promius Pharma, has out-licensed the…

Conatus Pharma Announces Completion Of Enrollment In ENCORE-NF Phase IIb Clinical Trial Of Emricasan In Patients With NASH Fibrosis

  Life Sciences Jobs   ...

Syndax to Present at the SITC 32nd Annual Scientific Meeting

Syndax-Sponsored Oral Presentation Title:ENCORE-601: Phase 1b/2 study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC) Presenter:...

Dr. Reddy's Laboratories Announces Out-Licensing of DFD-06 to Encore Dermatology

NewsThe drug is intended to be used for treatment of moderate to severe plaque psoriasis.

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

For Better or Worse? Couples' Time Together in Encore Adulthood.

This study examined the amount of time married couples share together in a new "encore adult" life course stage around the 50s, 60s, and 70s. Also investigated was the relationship between shared time...

Clinical Trials [17 Associated Clinical Trials listed on BioPortfolio]

3DKnee™ System vs. the MJS Knee System

The purpose of this study is to compare the survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System in a group of 600 patients for whom data col...

Retrospective Encore Reverse Shoulder Prosthesis Study

The purpose of this study is to evaluate the survivorship and efficacy of the Encore Reverse Shoulder Prosthesis in a group of no more than 50 subjects for whom data collection has already...

Efficacy of the CLP® Hip - Retrospective

The purpose of this study is to evaluate the survivorship and efficacy of the Encore CLP® Hip stem in a group of no more than 200 patients from whom data has already been collected.

Retrospective Study of the Linear™ Hip

The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.

Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia

The goal of this project is to evaluate an innovative psychosocial intervention package that will incorporate evidence-based treatment strategies to target the affective-motivational defic...

Companies [14 Associated Companies listed on BioPortfolio]

Encore, A Quintiles Company

Encore, A Quintiles Company, is an award-winning leader in health-information technology services and solutions. Founded in 2009 and led by Encore CEO Dana Sellers and President T...

Encore Health Resources

Encore Health Resources, founded by healthcare veterans Ivo Nelson and Dana Sellers, provides information technology consulting services to the provider segment of the healthcare ...

Encore Medical Technologies

Encore's trained technicians, some with over 25 years of renovation experience, use specialized equipment to create a superior product that looks and operates much like new equipment. From hospital be...

Encore Consumer Capital

Encore Consumer Capital is a San Francisco-based private equity investment firm focused on the consumer products industry. The firm has raised nearly $400 million in equity capita...

Encore Pharmaceuticals Inc.

Encore Pharmaceuticals Inc. (EncorePharma) is a drug discovery and development organization focused on early steps in streamlining the introduction of effective new products to the healthcare marketpl...

More Information about "Encore" on BioPortfolio

We have published hundreds of Encore news stories on BioPortfolio along with dozens of Encore Clinical Trials and PubMed Articles about Encore for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Encore Companies in our database. You can also find out about relevant Encore Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record